Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09IOF
|
|||
| Former ID |
DIB013489
|
|||
| Drug Name |
Troplasminogen alfa
|
|||
| Synonyms |
TAPgen; BB-10153; Thrombin activatable plasminogen, British Biotech; Thrombin activatable plasminogen, Vernalis
Click to Show/Hide
|
|||
| Indication | Myocardial infarction [ICD-11: BA41-BA43; ICD-9: 410] | Phase 2 | [1] | |
| Company |
Vernalis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00144014) Safety and Efficacy Study in Acute Ischaemic Stroke. U.S. National Institutes of Health. | |||
| REF 2 | V-10153 (Vernalis). Curr Opin Investig Drugs. 2005 Sep;6(9):951-5. | |||
| REF 3 | Tranexamic acid in trauma: how should we use it. J Trauma Acute Care Surg. 2013 Jun;74(6):1575-86. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.